<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Extranodal <z:hpo ids='HP_0002665'>lymphomas</z:hpo> are increasing in frequency owing in part to a true increase, but also as a consequence of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AIDS</z:e> and the recognition by pathologists that many cases formerly regarded as extranodal <z:mp ids='MP_0000688'>lymphoid hyperplasias</z:mp> or as <z:e sem="disease" ids="C0221269" disease_type="Disease or Syndrome" abbrv="">pseudolymphomas</z:e> are low-grade <z:hpo ids='HP_0002665'>lymphomas</z:hpo> of mucosa-associated lymphoid tissue (MALT) type </plain></SENT>
<SENT sid="1" pm="."><plain>However, most primary extranodal <z:hpo ids='HP_0002665'>lymphomas</z:hpo> are aggressive <z:hpo ids='HP_0002665'>lymphomas</z:hpo>, usually of large B-cell type </plain></SENT>
<SENT sid="2" pm="."><plain>Extranodal T-cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> also occur, such as the NK/T-cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> of the sinonasal area, the subcutaneous panniculitic T-cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo>, and anaplastic large cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>The aggressive <z:hpo ids='HP_0002665'>lymphomas</z:hpo> need to be distinguished from extranodal myeloid <z:hpo ids='HP_0001909'>leukemias</z:hpo>, whereas the low-grade <z:hpo ids='HP_0002665'>lymphomas</z:hpo> of MALT need to be distinguished from other extranodal <z:hpo ids='HP_0002665'>lymphomas</z:hpo> composed of small lymphocytes, such as mantle cell and follicular <z:hpo ids='HP_0002665'>lymphomas</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>MALT <z:hpo ids='HP_0002665'>lymphomas</z:hpo> also must be differentiated from the various forms of extranodal <z:mp ids='MP_0000688'>lymphoid hyperplasia</z:mp> </plain></SENT>
<SENT sid="5" pm="."><plain>Caution is required when determining this differentiation, since the discovery of a clonal cell population in a clinically and pathologically innocuous extranodal lymphocytic infiltrate does not necessarily equate with a diagnosis of malignant <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>In this setting, a more appropriate designation might be a <z:hpo ids='HP_0002664'>neoplasm</z:hpo> or disorder of "uncertain malignant potential." </plain></SENT>
</text></document>